Cargando…
“A LEAP 2 conclusions? Targeting the ghrelin system to treat obesity and diabetes”
BACKGROUND: The hormone ghrelin stimulates food intake, promotes adiposity, increases body weight, and elevates blood glucose. Consequently, alterations in plasma ghrelin levels and the functioning of other components of the broader ghrelin system have been proposed as potential contributors to obes...
Autores principales: | Gupta, Deepali, Ogden, Sean B., Shankar, Kripa, Varshney, Salil, Zigman, Jeffrey M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085568/ https://www.ncbi.nlm.nih.gov/pubmed/33246141 http://dx.doi.org/10.1016/j.molmet.2020.101128 |
Ejemplares similares
-
OR12-04 LEAP2 Deletion Does Not Counteract The Effects Of Ghrelin Deletion During Insulin-Induced-Hypoglycemia
por: Shankar, Kripa, et al.
Publicado: (2023) -
LEAP2 deletion in mice enhances ghrelin's actions as an orexigen and growth hormone secretagogue
por: Shankar, Kripa, et al.
Publicado: (2021) -
Role of Growth Hormone in Ghrelin’s Metabolic Actions
por: Gupta, Deepali, et al.
Publicado: (2021) -
Ghrelin cell–expressed insulin receptors mediate meal- and obesity-induced declines in plasma ghrelin
por: Shankar, Kripa, et al.
Publicado: (2021) -
THU309 Ghrelin Deficiency Does Not Improve Glucose Tolerance And Insulin Secretion In Female Mice
por: Gupta, Deepali, et al.
Publicado: (2023)